Vergent Bioscience’s breakthrough at STS 2024: VGT-309 enhances lung cancer surgery
At the 60th Annual Meeting of The Society of Thoracic Surgeons (#STS2024), Vergent Bioscience, a Minneapolis-based clinical-stage biotechnology company, presented compelling new data about VGT-309, ... Read More